Skip to Main Content

Paper Details

Delta NT-proBNP predicts cardiotoxicity in HER2-positive breast cancer patients treated with trastuzumab.
Acta Oncol
5
2021
Author NameAffiliation
Barbro LinderholmInstitute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg
Barbro LinderholmSahlgrenska University Hospital
  • 1 - 2

Datasets

Release 1.2